Vivoryon Therapeutics N.V. (AMS: VVY)
Netherlands
· Delayed Price · Currency is EUR
2.175
+0.075 (3.57%)
Jan 3, 2025, 5:35 PM CET
Vivoryon Therapeutics Revenue
Vivoryon Therapeutics had revenue of -3.62M EUR in the twelve months ending June 30, 2024. In the year 2023, Vivoryon Therapeutics had annual revenue of -3.62M.
Revenue
-3.62M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
-241.33K
Employees
15
Market Cap
56.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVivoryon Therapeutics News
- 24 days ago - Vivoryon Therapeutics NV (STU:05Y) Q3 2024 Earnings Call Highlights: Strategic Shifts and ... - GuruFocus
- 24 days ago - Q3 2024 Vivoryon Therapeutics NV Earnings Call Transcript - GuruFocus